Risk factor analysis and outcomes of heart transplant recipients infected by COVID-19
COVID-19 vaccination is recommended for HTxs to reduce severe outcomes and mortality. Sirolimus use was independently associated with severe infection, highlighting the need for careful management of immunosuppression.
Authors
- Sipeng Chen (ORCID: https://orcid.org/0009-0007-1005-8854)
- Shanshan Zheng
- Jie Huang (ORCID: https://orcid.org/0000-0002-3423-5532)
- Zhongkai Liao
- Sheng Hong Liu (ORCID: https://orcid.org/0000-0001-5933-1101)
- Xiaonan Fang (ORCID: https://orcid.org/0000-0002-4787-5977)
- Lin Zhang (ORCID: https://orcid.org/0009-0003-9331-9159)
- Xiaoying Hu (ORCID: https://orcid.org/0000-0003-3712-4229)
- Chenfei Rao
- Zhe Zheng
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-30
- DOI
- https://doi.org/10.3389/fimmu.2025.1597333
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40